Document 0746 DOCN M9550746 TI Association of alterations in NF-kappa B moieties with HIV type 1 proviral latency in certain monocytic cells. DT 9505 AU Oakes JW; Bagasra O; Duan L; Pomerantz RJ; Department of Medicine, Dorrance H. Hamilton Laboratories,; Jefferson Medical College, Thomas Jefferson University,; Philadelphia, Pennsylvania 19104. SO AIDS Res Hum Retroviruses. 1994 Oct;10(10):1213-9. Unique Identifier : AIDSLINE MED/95151358 AB Human immunodeficiency virus type 1 (HIV-1) replication is controlled by a complex array of virally encoded and cellular proteins. A wide spectrum of levels of HIV-1 expression have been demonstrated in various cells, both in cell culture and in vivo. Molecular mechanisms leading to restricted HIV-1 replication may differ between certain cell types. It is now demonstrated that HIV-1 proviral latency in the monocytic cell line U1, in which only extremely low levels of HIV-1 expression are detected in the baseline unstimulated state, is associated with alterations in nuclear factor-kappa B (NF-kappa B) moieties demonstrated in these cells by electrophoretic mobility shift assays (EMSAs) and in situ UV cross-linking studies. A predominance of p50 NF-kappa B moieties and possibly p50 homodimers or closely related species, rather than the p50-p56 heterodimer of NF-kappa B that is the predominant NF-kappa B species in most T lymphocytic and monocytic cells, is demonstrated in the nuclei of U1 cells. This pattern of NF-kappa B-related moieties differs from the latently infected T lymphocytic cell line ACH-2, and from the U937 monocytic line, the parental cell line of the U1 cellular clone. As such, these data suggest that different proximal mechanisms may lead to restricted HIV-1 replication in various cell types. DE Base Sequence Binding Sites Cell Line Electrophoresis, Polyacrylamide Gel Human HIV-1/*PHYSIOLOGY Molecular Sequence Data Monocytes/*PHYSIOLOGY/*VIROLOGY NF-kappa B/*BIOSYNTHESIS/ISOLATION & PURIF Oligonucleotide Probes Proviruses/*PHYSIOLOGY Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. Virus Latency JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).